4//SEC Filing
MASSARO GEORGE 4
Accession 0001127602-25-014486
CIK 0001100682other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:41 PM ET
Size
12.4 KB
Accession
0001127602-25-014486
Insider Transaction Report
Form 4
MASSARO GEORGE
Director
Transactions
- Sale
Common Stock
2025-05-14$139.95/sh−91$12,735→ 5,764 total - Sale
Common Stock
2025-05-14$140.78/sh−21$2,956→ 5,743 total - Sale
Common Stock
2025-05-14$141.85/sh−14$1,986→ 5,729 total - Sale
Common Stock
2025-05-14$143.77/sh−7$1,006→ 5,722 total - Sale
Common Stock
2025-05-14$145.54/sh−7$1,019→ 5,715 total
Footnotes (5)
- [F1]This transaction was executed in multiple trades at prices ranging from $139.47 to $140.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $140.52 to $141.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
- [F3]This transaction was executed in multiple trades at prices ranging from $141.80 to $141.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
- [F4]This transaction was executed in multiple trades at prices ranging from $143.70 to $143.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
- [F5]This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
Documents
Issuer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CIK 0001100682
Entity typeother
Related Parties
1- filerCIK 0001221496
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:41 PM ET
- Size
- 12.4 KB